|By Business Wire||
|November 29, 2016 07:00 PM EST|
BioCision, LLC, a life science research and development company that standardizes basic laboratory processes, today announced the formation of MedCision, Inc., an independent company focused on automation of pre-clinical and clinical processes.
“The formation of MedCision is driven by a critical need in the market – innovative, standardization technologies and solutions for translational, clinical and point-of-care settings,” said Rolf O. Ehrhardt, MD, PhD, BioCision CEO. “MedCision will be a leader in developing and commercializing innovative instruments for crucial processes in the post-manufacturing cell and gene therapy space.”
Dr. Ehrhardt continued, “The name of the company, MedCision, creates a clear connection to our BioCision roots but also conveys an evolution from those roots as our technology will focus on automating point-of-care clinical processes.”
The creation of MedCision as a stand-alone company with a dedicated management team will provide the necessary focus and foundation for long-term value generation in the clinical tools space. Commercialization of the award-winning ThawSTAR® cell thawing platform will initially be the focus of MedCision.
Cell thawing, the last step a cellular product undergoes before patient administration, is one of the most important parts of the post manufacturing process. Rapid, uniform, non-fluid based thawing is necessary to maintaining therapeutic efficacy. ThawSTAR’s automated cell thawing platform makes it easy to ensure proper clinical handling and thawing across a range of volumes and storage formats. At the same time, the platform automatically incorporates temperature monitoring and data connectivity, both of which are critical to ensuring proper sample tracking and patient safety.
The ThawSTAR platform is experiencing rapid adoption into cell therapy research and development as part of clinical trials and will accelerate with the soon-to-be-announced Early Adopter Program. As the flagship product of this new company, the ThawSTAR platform will be expanded over the next 12 months with additional models and features.
MedCision corporate offices will be headquartered in San Rafael, California and spearheaded by former members of the BioCision senior management team. Rolf Ehrhardt, will serve as President and CEO, Ron DiNocco, Chief Financial Officer and VP of Corporate Development, Eric Kunkel, SVP of Research and Development and Sam Kent, SVP Global Sales and Business Development.
Through cutting edge science, engineering and software, MedCision develops and commercializes standardization and automation technologies for vital preclinical and clinical sample handling. MedCision’s instrumentation will advance near patient drug management by providing controlled and scalable processing of temperature-sensitive products.
BioCision is a research and development company that provides passive tools to standardize critical processes throughout the life science industry. BioCision’s products can be integrated throughout research, development and manufacturing workflows, enabling consistent temperature control for sensitive biological samples. By addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development.
Dec. 5, 2016 07:15 PM EST Reads: 5,029
Dec. 5, 2016 07:15 PM EST Reads: 343
Dec. 5, 2016 07:15 PM EST Reads: 2,045
Dec. 5, 2016 07:00 PM EST Reads: 1,802
Dec. 5, 2016 07:00 PM EST Reads: 1,837
Dec. 5, 2016 06:15 PM EST Reads: 1,546
Dec. 5, 2016 05:45 PM EST Reads: 1,587
Dec. 5, 2016 05:15 PM EST Reads: 1,682
Dec. 5, 2016 04:30 PM EST Reads: 871
Dec. 5, 2016 04:30 PM EST Reads: 2,048
Dec. 5, 2016 04:15 PM EST Reads: 856
Dec. 5, 2016 04:00 PM EST Reads: 2,550
Dec. 5, 2016 03:45 PM EST Reads: 4,243
Whether your IoT service is connecting cars, homes, appliances, wearable, cameras or other devices, one question hangs in the balance – how do you actually make money from this service? The ability to turn your IoT service into profit requires the ability to create a monetization strategy that is flexible, scalable and working for you in real-time. It must be a transparent, smoothly implemented strategy that all stakeholders – from customers to the board – will be able to understand and comprehe...
Dec. 5, 2016 03:45 PM EST Reads: 331
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, discussed why and how ReadyTalk diverted from healthy revenue and mor...
Dec. 5, 2016 02:45 PM EST Reads: 1,590